Article
The G1246A polymorphism in the hypocretin receptor 2 gene is not associated with treatment response in cluster headache.
Cephalalgia : an international journal of headache - 1 Apr 2007
Schürks M, Kurth T, Geissler I, Tessmann G, Diener H-C, Rosskopf D
Abstract excerpt
The risk of cluster headache (CH) is associated with the G-allele of the G1246A polymorphism in the hypocretin receptor 2 (HCRTR2) gene. First-line medication is effective in only about 70-80% of CH patients. We hypothesized that the HCRTR2 G1246A polymorphism is also of pharmacogenetic relevance in CH and may affect treatment response. We performed a prospective cohort study among 184 unrelated White CH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
